摘要
目的探讨PDCA循环管理模式在肺癌化疗患者经外周静脉穿刺的中心静脉导管(PICC)置管中的应用效果。方法根据PICC置管干预方法的不同将120例肺癌化疗患者分为对照组(n=57,常规干预)和PDCA组(n=63,在对照组的基础上采取PDCA循环管理模式)。比较两组患者的自我护理能力[自我护理能力测定量表(ESCA)]、生活质量[肺癌患者生活质量测定量表(FACT-L)]、PICC置管依从性、导管不良事件及并发症发生情况。结果干预后,两组患者ESCA各维度评分、FACT-L各维度评分及总分均升高,且PDCA组患者ESCA各维度评分、FACT-L各维度评分及总分均高于对照组,差异均有统计学意义(P﹤0.05)。PDCA组患者PICC置管依从性优于对照组,导管不良事件总发生率和并发症总发生率均低于对照组,差异均有统计学意义(P﹤0.05)。结论对PICC置管的肺癌化疗患者采取PDCA循环管理模式,可提高自我护理能力、生活质量及PICC置管依从性,降低导管不良事件和并发症的发生率。
Objective To explore the application effect of PDCA cycle management mode in lung cancer patients with peripherally inserted central venous catheter(PICC)catheterization during chemotherapy.Method According to different PICC catheterization intervention methods,120 patients with lung cancer who underwent chemotherapy were di-vided into control group(n=57,conventional intervention)and PDCA group(n=63,PDCA cycle management mode was adopted on the basis of control group).The self-care ability[exercise of self-care agency(ESCA)],quality of life[func-tional assessment of cancer therapy-lung(FACT-L)],PICC catheterization compliance,catheter adverse events and com-plications were compared between the two groups.Result After intervention,the dimensional scores of ESCA,the di-mensional scores and total scores of FACT-L in both groups were increased,and the dimensional scores of ESCA,the di-mensional scores and total score of FACT-L in PDCA group were higher than those in control group,the differences were statistically significant(P<0.05).The PICC catheterization compliance in PDCA group was better than that in control group,and the total incidences of catheter adverse events and complications were lower than those in control group,the differences were statistically significant(P<0.05).Conclusion The PDCA cycle management mode in lung cancer pa-tients with PICC catheterization during chemotherapy can improve self-care ability,quality of life and PICC catheteriza-tion compliance,and reduce the incidences of catheter adverse events and complications.
作者
张丽娜
马宁
郑夏
ZHANG Li’na;MANing;ZHENG Xia(Second Ward,Department of Respiratory and Critical Care Medicine,Luohe Central Hospital(the First Affiliated Hospital of Luohe Medical College),Luohe 462300,He’nan,China)
出处
《癌症进展》
2025年第8期981-984,共4页
Oncology Progress
